Literature DB >> 16894244

Historical perspectives on the management of hypertension.

Marvin Moser1.   

Abstract

As late as the 1950s, elevated blood pressure was considered by many expert physicians to be necessary for the adequate perfusion of vital organs. Although the morbidity and mortality risks of hypertension were known at that time to insurance companies, which often refused life insurance policies to people with high blood pressure, there was a lag in the recognition of the dangers of hypertension in the medical community. Following the pioneering efforts of researchers who began to treat patients with malignant hypertension, the results of clinical trials and population studies, and the availability of effective antihypertensive agents, hypertension management improved rapidly. This review traces the history of hypertension management from the 1940s, when President Franklin Delano Roosevelt died of a cerebrovascular accident-a result of uncontrolled hypertension-to today, when a large number of patients, even those with less severe hypertension, are being treated successfully, with a resulting dramatic decrease in hypertension-related vascular disease.

Entities:  

Mesh:

Year:  2006        PMID: 16894244      PMCID: PMC8109518          DOI: 10.1111/j.1524-6175.2006.05836.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  24 in total

1.  Desperate diseases, desperate measures: tackling malignant hypertension in the 1950s.

Authors:  H O Ventura; M R Mehra; F H Messerli
Journal:  Am Heart J       Date:  2001-08       Impact factor: 4.749

2.  I. Critical evaluation of drug therapy of hypertension.

Authors:  M MOSER; T W MATTINGLY
Journal:  Postgrad Med       Date:  1955-05       Impact factor: 3.840

3.  Chlorothiazide as an adjunct in the treatment of essential hypertension.

Authors:  M MOSER; A I MACAULAY
Journal:  Am J Cardiol       Date:  1959-02       Impact factor: 2.778

4.  Hypertensive vascular disease; description and natural history.

Authors:  G A PERERA
Journal:  J Chronic Dis       Date:  1955-01

5.  Evolution of the treatment of hypertension from the 1940s to JNC V.

Authors:  M Moser
Journal:  Am J Hypertens       Date:  1997-03       Impact factor: 2.689

6.  Clinical notes on the illness and death of President Franklin D. Roosevelt.

Authors:  H G Bruenn
Journal:  Ann Intern Med       Date:  1970-04       Impact factor: 25.391

7.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

8.  Blood pressure and risk of coronary heart disease: the Framingham study.

Authors:  W B Kannel; M J Schwartz; P M McNamara
Journal:  Dis Chest       Date:  1969-07

9.  Hypertension icons: Henry R. Black's interview with Marvin Moser, MD.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-01       Impact factor: 3.738

10.  Hypertension treatment--a success study.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

View more
  23 in total

1.  Lifestyle interventions in the management of hypertension: a survey based on the opinion of 105 practitioners.

Authors:  S Elhani; T J Cleophas; R Atiqi
Journal:  Neth Heart J       Date:  2009-01       Impact factor: 2.380

2.  Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States.

Authors:  Amanda Kelly; Matthew Calamia; Andrey Koval; Graciela Muniz Terrera; Andrea M Piccinin; Sean Clouston; Linda B Hassing; David A Bennett; Boo Johansson; Scott M Hofer
Journal:  Psychol Aging       Date:  2016-02-25

3.  Epidemiology of Stroke: Legacy of the Framingham Heart Study.

Authors:  Jose R Romero; Philip A Wolf
Journal:  Glob Heart       Date:  2013-03-15

Review 4.  The treatment of hypertension during pregnancy: when should blood pressure medications be started?

Authors:  Dawn C Scantlebury; Gary L Schwartz; Letitia A Acquah; Wendy M White; Marvin Moser; Vesna D Garovic
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

5.  Vascular disease and type 2 diabetes: the science policy case for early cardiometabolic intervention.

Authors:  David Taylor
Journal:  Cardiovasc Endocrinol Metab       Date:  2019-05-15

6.  Global perspective on acute coronary syndrome: a burden on the young and poor.

Authors:  Rajesh Vedanthan; Benjamin Seligman; Valentin Fuster
Journal:  Circ Res       Date:  2014-06-06       Impact factor: 17.367

Review 7.  The discovery of hypertension: evolving views on the role of the kidneys, and current hot topics.

Authors:  Richard J Johnson; Miguel A Lanaspa; L Gabriela Sánchez-Lozada; Bernardo Rodriguez-Iturbe
Journal:  Am J Physiol Renal Physiol       Date:  2014-11-05

Review 8.  Renal infiltration of immunocompetent cells: cause and effect of sodium-sensitive hypertension.

Authors:  Bernardo Rodriguez-Iturbe
Journal:  Clin Exp Nephrol       Date:  2010-02-19       Impact factor: 2.801

Review 9.  Dysregulated Blood Pressure: Can Regulating Emotions Help?

Authors:  Claudia Trudel-Fitzgerald; Paola Gilsanz; Murray A Mittleman; Laura D Kubzansky
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

10.  Antihypertensive drug treatment: the real-life challenge.

Authors:  Konstantinos P Imprialos; Konstantinos Stavropoulos; Michael Doumas
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-08       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.